Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Hsiao, Jen Hsiang T ^a   Fu, YuHong ^a   Hill, Andrew F ^b,c   Halliday, Glenda M ^a,d   Kim, Woojin Scott ^a,d  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; SPHINGOMYELIN; APP PROTEIN, HUMAN; BRIDGED COMPOUND; MEMBRANE PROTEIN; NERVE PROTEIN; PHOSPHOTRANSFERASE; SGMS1 PROTEIN, HUMAN; SPHINGOLIPID; THIOKETONE; TRICYCLODECANE-9-YL-XANTHOGENATE;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; FEMALE; GENE; GENE ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; NONHUMAN; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SGMS1 GENE; ANIMAL; BIOSYNTHESIS; CASE CONTROL STUDY; CELL SURVIVAL; CHO CELL LINE; CRICETULUS; DEMOGRAPHY; DRUG EFFECTS; GENE EXPRESSION REGULATION; HAMSTER; METABOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRIDGED COMPOUNDS; CASE-CONTROL STUDIES; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DEMOGRAPHY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPHINGOLIPIDS; THIONES; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 84882582316     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074016     Document Type: Article

References (37)

1. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736. doi:10.1038/325733a0. PubMed: 2881207.
2. Selkoe DJ, (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766. PubMed: 11274343.
3. Bales KR, Du Y, Holtzman D, Cordell B, Paul SM, (2000) Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol Aging 21: 427-432; discussion 451-423 doi:10.1016/S0197-4580(00)00143-3. PubMed: 10858588.
4. Grimm MO, Grimm HS, Pätzold AJ, Zinser EG, Halonen R, et al. (2005) Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol 7: 1118-1123. doi:10.1038/ncb1313. PubMed: 16227967.
5. Smith DG, Cappai R, Barnham KJ, (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 1768: 1976-1990. doi:10.1016/j.bbamem.2007.02.002. PubMed: 17433250.
6. Ward RV, Jennings KH, Jepras R, Neville W, Owen DE, et al. (2000) Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J 3481:: 137-144. doi:10.1042/0264-6021:3480137. PubMed: 10794724.
7. Foley P, (2010) Lipids in Alzheimer's disease: A century-old story. Biochim Biophys Acta 1801: 750-753. doi:10.1016/j.bbalip.2010.05.004. PubMed: 20471492.
8. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43: 436-441. doi:10.1038/ng.801. PubMed: 21460841.
9. Bu G, (2009) Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10: 333-344. doi:10.1038/nrn2620. PubMed: 19339974.
10. Xu Q, Brecht WJ, Weisgraber KH, Mahley RW, Huang Y, (2004) Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J Biol Chem 279: 25511-25516. doi:10.1074/jbc.M311256200. PubMed: 15054100.
11. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, et al. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem 269: 23403-23406. PubMed: 8089103.
12. Tokuda T, Calero M, Matsubara E, Vidal R, Kumar A, et al. (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J 3482:: 359-365. doi:10.1042/0264-6021:3480359. PubMed: 10816430.
13. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435. doi:10.1038/ng.803. PubMed: 21460840.
14. Chan SL, Kim WS, Kwok JB, Hill AF, Cappai R, et al. (2008) ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro. J Neurochem 106: 793-804. doi:10.1111/j.1471-4159.2008.05433.x. PubMed: 18429932.
15. Kim WS, Li H, Ruberu K, Chan S, Elliott DA, et al. (2013) Deletion of Abca7 Increases Cerebral Amyloid-beta Accumulation in the J20 Mouse Model of Alzheimer's Disease. J Neurosci 33: 4387-4394. doi:10.1523/JNEUROSCI.4165-12.2013. PubMed: 23467355.
16. Ehehalt R, Keller P, Haass C, Thiele C, Simons K, (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160: 113-123. doi:10.1083/jcb.200207113. PubMed: 12515826.
17. Vetrivel KS, Cheng H, Kim SH, Chen Y, Barnes NY, et al. (2005) Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J Biol Chem 280: 25892-25900. doi:10.1074/jbc.M503570200. PubMed: 15886206.
18. Glaros EN, Kim WS, Quinn CM, Wong J, Gelissen I, et al. (2005) Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator. J Biol Chem 280: 24515-24523. doi:10.1074/jbc.M413862200. PubMed: 15890646.
19. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, et al. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 95: 6460-6464. doi:10.1073/pnas.95.11.6460. PubMed: 9600988.
20. Tamboli IY, Prager K, Barth E, Heneka M, Sandhoff K, et al. (2005) Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide. J Biol Chem 280: 28110-28117. doi:10.1074/jbc.M414525200. PubMed: 15923191.
21. Mathias S, Peña LA, Kolesnick RN, (1998) Signal transduction of stress via ceramide. Biochem J 335(3):: 465-480. PubMed: 9794783.
22. Brady RO, Kanfer JN, Mock MB, Fredrickson DS, (1966) The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci U S A 55: 366-369. doi:10.1073/pnas.55.2.366. PubMed: 5220952.
23. Nixon RA, (2004) Niemann-Pick Type C disease and Alzheimer's disease: the APP-endosome connection fattens up. Am J Pathol 164: 757-761. doi:10.1016/S0002-9440(10)63163-X. PubMed: 14982829.
24. (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18: S1-S2. doi:10.1016/S0197-4580(97)00057-2. PubMed: 9330978.
25. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, et al. (2006) Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 281: 17670-17680. doi:10.1074/jbc.M602487200. PubMed: 16648635.
26. Hojjati MR, Jiang XC, (2006) Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res 47: 673-676. PubMed: 16371647.
27. Wing DR, Garner B, Hunnam V, Reinkensmeier G, Andersson U, et al. (2001) High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide. Anal Biochem 298: 207-217. doi:10.1006/abio.2001.5393. PubMed: 11700975.
28. Gregory GC, Macdonald V, Schofield PR, Kril JJ, Halliday GM, (2006) Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Neurobiol Aging 27: 387-393. doi:10.1016/j.neurobiolaging.2005.03.011. PubMed: 15894410.
29. Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, et al. (2012) Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem 287: 2678-2688. doi:10.1074/jbc.M111.274142. PubMed: 22134919.
30. Fabelo N, Martin V Marin R, Santpere G, Aso Eet al. (2012) Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease. J Neuropathol Exp Neurol 71: 868-881. doi:10.1097/NEN.0b013e31826be03c. PubMed: 22975585.
31. Tafesse FG, Ternes P, Holthuis JC, (2006) The multigenic sphingomyelin synthase family. J Biol Chem 281: 29421-29425. doi:10.1074/jbc.R600021200. PubMed: 16905542.
32. Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC, (2004) Identification of a family of animal sphingomyelin synthases. EMBO J 23: 33-44. doi:10.1038/sj.emboj.7600034. PubMed: 14685263.
33. Li H, Kim WS, Guillemin GJ, Hill AF, Evin G, et al. (2010) Modulation of amyloid precursor protein processing by synthetic ceramide analogues. Biochim Biophys Acta 1801: 887-895. doi:10.1016/j.bbalip.2010.05.012. PubMed: 20599631.
34. Kalvodova L, Kahya N, Schwille P, Ehehalt R, Verkade P, et al. (2005) Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem 280: 36815-36823. doi:10.1074/jbc.M504484200. PubMed: 16115865.
35. Osenkowski P, Ye W, Wang R, Wolfe MS, Selkoe DJ, (2008) Direct and potent regulation of gamma-secretase by its lipid microenvironment. J Biol Chem 283: 22529-22540. doi:10.1074/jbc.M801925200. PubMed: 18539594.
36. Hoetzl S, Sprong H, van Meer G, (2007) The way we view cellular (glyco)sphingolipids. J Neurochem 103 (Suppl 1):: 3-13. doi:10.1111/j.1471-4159.2007.04721.x. PubMed: 17986134.
37. Tamboli IY, Hampel H, Tien NT, Tolksdorf K, Breiden B, et al. (2011) Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation. J Neurosci 31: 1837-1849. doi:10.1523/JNEUROSCI.2954-10.2011. PubMed: 21289194.